WhatsApp
Losna Absinthe hebal tea | Artemisia absinthium

Artemisia Annua Herbal Tea

ARTEMANNU-050
In Stock
€3.50
Tax included

Portugal and Spain

MRW ECONOMICO - from 2.99 euro

CORREIO NORMAL ILHAS - from 3.50 euro

CORREIO REGISTADO ILHAS ESPANHOLAS - from 4.99 euro

Europe

CORREIO REGISTADO INTERNACIONAL - from 6.99 euro

DELNEXT EUROPA - from 8.99 euro

UPS EUROPA - from 9.99 euro

DHL EUROPA - from 16.99 euro

Rest of the World

DHL EXPRESS - from 22.99 euro

Artemisia Tea | Antivirus

Weigth
Categories :

Artemisia Annua Herbal Tea

Ingredients: 100% Artemisia Annua plant.

Artemisia is a medicinal plant known as Chamomile-do-rainha-campo, como-das Erva-de-Rainha-fogo, for women, which are used for problems, for treating urogenital, such as urinary tract infection, popularly, as concerned with the women. .

Side effects damisia, vasodilation, seizures and allergic reactions can cause, as they are used during pregnancy and cannot be aborted.

What is it for:

Artemisia has different species of different plants and each one has its characteristics, benefits and contraindications.

This plant is antispasmodic, used only as an analgesic, antispasmodic, anticonvulsant, treatment of dyspepsia, rheumatism, fevers, anemia, absence of menstruation, colic and to expel intestinal, scientifically the benefits:

Helps protect the liver.

It exerts antifungal, broad-spectrum antibacterial and anthelmintic (against worms) action.

It helps to improve mood.

Improves the quality of life of patients with Crohn's disease.

Exerts an anti-oxidant action, protected for brain and stroke protection.

It helps prevent certain types of cancer, especially acute myeloid leukemia.

By Dr. Tomislav Meštrović, MD, Ph.D.

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

A multinational research group has been the first to show the excellent activity of artemisinin-based treatment against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cell lines – including a specific type of lung cells. Their findings were recently published in the journal Scientific Reports.

Notwithstanding the increasing availability of vaccines against the coronavirus disease 2019 (COVID-19), we are still in need for effective and affordable treatments. There were many attempts to repurpose drugs that we already use for a myriad of different indications but to not much avail.

Artemisinin is one of many bioactive compounds present in the plant known as Artemisia annua, and is currently used as an active ingredient to treat malaria. Moreover, its derivates, artesunate, and artemether come with even better pharmacokinetic traits, which is why they are pervasively used in various anti-malaria combination treatments around the world.

Considering their excellent safety profiles in humans, as well as their potential for worldwide distribution at relatively low costs, artemisinin-based drugs appear to be an attractive repurposing drug candidate for COVID-19.

However, while an antiviral potential of artemisinin, its derivatives, and plant extracts have been demonstrated for several viral groups, it is still not clear whether they would actually be viable in the treatment of COVID-19 due to their elusive mechanisms of action.

This new study, led by Dr. Yuyong Zhou from the University of Copenhagen in Denmark and Dr. Kerry Gilmore from the Max Planck Institute for Colloids and Interfaces in Germany, aimed to appraise whether Artemisia annua extracts – but also pure artemisinin, artesunate and artemether – are active against SARS-CoV-2 in the laboratory conditions.

Total rating:
0 1 2 3 4
5,00/5
Based on 1 review
Filter:
0 1 2 3 0 (0)
0 1 2 0 1 (0)
0 1 0 1 2 (0)
0 0 1 2 3 (0)
0 1 2 3 4
(5/5

Cha

Ervas de escelente qualidade. Recomendo.

Page: 1